Yale Cancer Center member, David Schatz, PhD, has been named fellows of the American Association for the Advancement of Science (AAAS), the largest international organization dedicated to advancing science, engineering, and innovation.
Schatz was recognized for his “distinguished contributions to our understanding of the mechanisms that assemble and diversify antigen receptor genes that encode antibodies and T cell receptors.” Schatz is best known for the discovery of RAG1 and RAG2 (recombination-activating genes), subsequent biochemical insights into RAG function and evolutionary origins, and the discovery of two distinct levels of regulation of somatic hypermutation.
Schatz joined the Yale faculty in 1991. He received B.S. and M.S. degrees in molecular biophysics and biochemistry from Yale University in 1980, and a M.A. degree in philosophy and politics from Oxford University in 1982. His Ph.D. degree (1990) and postdoctoral training were done with Dr. David Baltimore at the Massachusetts Institute of Technology and the Whitehead Institute for Biomedical Research.
AAAS is the world’s largest general scientific society and publisher of the journal Science as well as Science Translational Medicine and Science Signaling. AAAS was founded in 1848, and includes 254 affiliated societies and academies of science, serving 10 million individuals.